Tesla Fights Back: Appeals $243 Million Verdict Amid Claims of Jury Misleading Over Autopilot Liability

MIAMI — Tesla is appealing a $243 million verdict linked to a fatal crash involving its Autopilot technology, claiming the jury was misled during the trial. The appeal was filed in federal court, where the company is seeking to overturn the ruling, request a new trial, or significantly lower the damages awarded. This case stems from a tragic accident in 2019 that resulted in the death of 22-year-old Naibel Benavides. The lawsuit, which concluded with a jury finding the driver predominantly at fault, nonetheless implicated Tesla’s Autopilot system as a contributing factor. Benavides’ family, along … Read more

Rocket Pharmaceuticals Investors Urged to Join Class Action Ahead of August 11 Deadline, Claims of Misleading Trial Data Surface

NEW YORK — Investors who purchased shares of Rocket Pharmaceuticals, Inc. between February 27 and May 26, 2025, are being reminded of an upcoming deadline related to a class action lawsuit. The Rosen Law Firm, a prominent global investor rights law firm, has announced that August 11, 2025, is the last day to apply as a lead plaintiff in this case. Those who bought securities of Rocket Pharmaceuticals during the specified period may be eligible for compensation without any upfront costs. Prospective participants can contact Phillip Kim, a legal representative from Rosen Law Firm, for … Read more

Gleeson Asphalt Secures $109 Million Victory in Dispute Over Misleading Construction Materials

ST. LOUIS, Mo. — Gleeson Asphalt prevailed in a significant legal battle, securing a $109 million verdict after a jury determined the company was misled regarding the quality of construction rock essential for its projects. The case revolved around allegations that a supplier, whose identity was not disclosed, provided Gleeson Asphalt with inferior materials, affecting the company’s operations and financial performance. The verdict was announced after a week-long trial, which drew considerable attention due to the high stakes involved. The jury’s decision underscores the critical importance of transparency and honesty in business dealings, particularly in … Read more

Organon Investors Urged to Act: Class Action Deadline Approaches Amid Allegations of Misleading Statements

NEW YORK — Investors in Organon & Co. are being reminded of an important deadline in connection with a class action lawsuit filed against the company. The Rosen Law Firm, which specializes in representing investor rights, is urging individuals who purchased Organon securities from October 31, 2024, to April 30, 2025, to participate in this legal action. The deadline to apply as a lead plaintiff is July 22, 2025. Those who acquired securities during the specified period may have the right to seek compensation through a contingency fee arrangement, meaning they would not incur any … Read more